We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

13 hedge funds and large institutions have $905K invested in VIVEVE MED INC in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

18% more funds holding

Funds holding: 11 → 13 (+2)

58% less capital invested

Capital invested by funds: $2.13M → $905K (-$1.23M)

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
3
Reduced
2
Closed
4
Calls
$206K
Puts
–
Net Calls
+$206K
Net Calls Change
+$206K

Top Buyers

Rank Fund Capital Flow
1
ARTA
A.R.T. Advisors
New York
+$274K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$233K
3
BFM
Boothbay Fund Management
New York
+$155K
4
VF
Virtu Financial
New York
+$49.7K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$37K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$104K
2
FIA
FNY Investment Advisers
New York
-$71K
3
HighTower Advisors
HighTower Advisors
Illinois
-$2.67K
4
HPC
HM Payson & Co
Maine
-$171

VIVE Hedge Fund Activity: Q4 2019 in Review

13 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q4 2019, worth a combined $905K — down 58% from $2.13M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VIVE positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $274K. The largest seller was Goldman Sachs, exiting entirely with an estimated $104K sold.

  • 13 institutional investors held VIVEVE MED INC (VIVE) as of Q4 2019, up from 11 in Q3 2019.
  • Funds reported $905K of VIVEVE MED INC stock for Q4 2019, down 58% quarter-over-quarter.
  • 6 funds opened new VIVEVE MED INC positions in Q4 2019 and 4 closed out, a net change of +2 holders.
  • The largest VIVEVE MED INC buyer in Q4 2019 was A.R.T. Advisors, an estimated $274K added.
  • The largest VIVEVE MED INC seller in Q4 2019 was Goldman Sachs, an estimated $104K sold.

Based on aggregated 13F filings for Q4 2019.